相关实验视频
Updated: Jun 23, 2025
08:09
Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
11.4K
在C1-酶抑制剂缺乏的长期结果
Luong Hoang Long1, Tatsuya Fujioka1, Timothy J Craig2
1Department of iPS Cell and Regenerative Medicine, Kansai Medical University, Japan.
Asian Pacific journal of allergy and immunology
|June 15, 2024
概括
遗传性血管炎 (HAE) 是一种罕见的遗传性疾病,导致胀. 本综述探讨了C1抑制剂缺乏症.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 血管生物学 血管生物学
背景情况:
- 遗传性血管 (HAE) 是一种罕见的遗传性疾病,其特点是偶尔出现胀和潜在的气道阻塞.
- 它源于C1抑制剂 (C1-INH) 缺乏或功能障碍,导致布拉迪基宁过度激活和血管.
- 由于疾病异质性,诊断延迟很常见,影响患者的治疗结果.
研究的目的:
- 审查目前关于HAE患者C1-INH缺乏症的长期后果的知识,而不仅仅是血管.
- 突出新出现的证据,将HAE与心血管疾病,自身免疫疾病和恶性瘤的风险增加联系起来.
- 强调改善HAE患者的长期护理和生活质量.
主要方法:
- 对现有研究的文献综述和关于HAE.中C1-INH缺乏症的证据.
- 分析将HAE与诸如心血管疾病,自身免疫疾病和恶性瘤等并发症联系在一起的研究.
- 综合有关当前管理策略和未来研究方向的信息.
主要成果:
- 在HAE中C1-INH缺乏与血管之外的风险有关,包括心血管问题,自身免疫和癌症.
- 提高意识,诊断和预防措施提高了HAE患者的护理和生活质量.
- 焦点正在从按需治疗转向预防性策略,以减少发作频率.
结论:
- 在HAE中C1-INH缺乏需要更广泛的临床视角,考虑潜在的长期系统性影响.
- 对这些非血管的后果进行进一步的研究对于全面的HAE患者管理至关重要.
- 优化长期护理和解决并发性疾病可以显著改善HAE患者的整体福祉.
相关概念视频
01:26Anticholinesterase Agents: Poisoning and Treatment
845
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
845
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
611
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
611
01:14Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
01:20Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
659
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
659